Filter posts

Cancer Docs Weigh in on Medicare Part B Demo

This week, American Society of Clinical Oncology (ASCO) President Daniel Hayes, MD and CEO Clifford …

WSJ: A Piece of the Immunotherapy Puzzle Solved

Just two weeks ago, the New York Times published a series of articles deeming immunotherapy …

ICYMI: NYT Chronicles Advances in Cancer Landscape Due to Immunotherapy

This week, the New York Times published a series of articles titled Cell Wars which explores …

ASCO Publishes New "Value Framework" for Cancer Treatment Options

On Monday, the American Society of Clinical Oncology (ASCO) published “A Framework to Assess the …

The Power of Innovation

Today’s “Fox and Friends” included an informative segment about the staggering advances being made in …

What to Watch: Emperor of All Maladies; Killing Cancer

Cancer is a disease which affects almost 1.7 million people each year in America, and …

T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets

New approaches in cancer immunology are achieving promising early-stage results through novel techniques for arming …

New PhRMA report: Nearly 800 Cancer Medicines in Development

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) shows that biopharma …

The Hill: In War on Cancer, Patients at Risk of Becoming Commoditized

Ted Okon, executive director of the Community Oncology Alliance, highlights the significant progress the medical …

Mito What???

Mitochondrial Disease: The Most Common Disease You’ve Probably Never Heard of… About 20 years ago, …